SCYNEXIS is a premier drug discovery and development company that delivers effective and innovative drug pipeline solutions to our pharmaceutical, global health and life science partners. These solutions come through our proprietary cyclophilin inhibitor technology and through our fully integrated and highly experienced drug outsourcing and consultancy teams. SCYNEXIS’ success is demonstrated by the eleven pre-clinical drug candidates that we have delivered over the last five years.